BofA raised the firm’s price target on Herbalife (HLF) to $9 from $8 and keeps an Underperform rating on the shares. The firm adjusted its estimates after Q4 results came in “largely in line” and 2026 guidance was introduced.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLF: